Already Registered? Log In Now Not Registered?
Complete this form to enter the webcast. Already Registered?

(* indicates required field)

Complete this form to enter the webcast.
(* indicates required field)

This event is sponsored by Oracle. Oracle will have access to your personal information and may provide you with sales or product promotion information. Oracle will be responsible for managing their own use of your personal information. Please review Oracle's privacy policy to address any questions you have regarding their handling of your personal information.



*Denotes required.


CancerX: Reducing burden and disparities in cancer care

This webcast is now available on demand!


Rethink the possible. Explore trends, innovative technologies, industry collaborations, and leading-edge techniques to help you stay at the forefront of clinical research and safety solutions. Learn more about the Oracle Innovation Series
Event Overview: 

Cancer is a leading cause of death worldwide. Access, equity, and inclusion when developing and deploying new solutions to combat this disease remain paramount. The impact of cancer on people’s lives and their families is profound.

The White House has reignited the Cancer Moonshot initiative and set a new national goal: “if we work together, we can cut the death rate from cancer by at least 50% over the next 25 years and improve the experience of people and their families living with and surviving cancer. To achieve these goals, we must amplify digital innovation.”

Oracle is excited and honored to participate in the Cancer Moonshot's new CancerX public-private partnership. CancerX's inaugural project focuses on using digital innovation to reduce disparities and financial toxicity in cancer care and research. CancerX uses a three-pronged approach to generate impact in cancer research and care: conducting pre-competitive evidence generation; establishing an accelerator cohort; and leading demonstration projects.

Key Learning Objectives: 
  • Learn about the White House Moonshot and CancerX project approach and progress.
  • Hear about the scope of the inaugural project ‘Advancing Digital Innovation to Improve Equity and Reduce Financial Toxicity in Cancer Care and Research’ and the value it will add to the industry.
  • Impress upon the audience the urgency and opportunity for industry experts to make a difference for cancer patients worldwide.
Who Should Attend: 
  • Clinical researchers, data scientists, and clinical decision teams responsible for:
    • Clinical development planning and study design
    • Management of patients and measurement of clinical outcomes
    • Clinical data management, collecting and evaluating trial metrics
    • Project management of studies, process optimization, and operational excellence



For any technical questions please contact: Nicole Valle
nvalle@mjhevents.com




JENNIFER GOLDSACK
CEO
Digital Medicine Society (DiMe)

Jennifer C. Goldsack co-founded and serves as the CEO of the Digital Medicine Society (DiMe), a 501(c)(3) non-profit organization dedicated to advancing digital medicine to optimize human health. Jennifer’s research focuses on applied approaches to the safe, effective, and equitable use of digital technologies to improve health, healthcare, and health research. She is a member of the Roundtable on Genomics and Precision Health at the National Academies of Science, Engineering and Medicine and serves on the World Economic Forum Global Leadership Council on mental health.


STEPHEN KONYA
Senior Advisor
Office for the National Coordinator for Health Information Technology

Stephen Konya serves as the Senior Advisor to the Deputy National Coordinator, and Innovation Portfolio Lead for the Office of the National Coordinator for Health IT (ONC), U.S. Department of Health and Human Services (HHS). In addition to shaping the Agency’s long-term strategy, he also serves as the primary liaison to the White House Office of Science and Technology Policy (OSTP) and the external healthcare startup and investor community.

Furthermore, Mr. Konya also leads the Digital Health Innovation Workgroup under the Federal Health IT Coordinating Council, an interagency collaboration community comprised of innovation representatives from 40 other federal agencies. In addition to currently serving as the primary Federal Govt lead and Co-Founder for CancerX, Mr. Konya has previously led several other key federal projects, including the HHS PandemicX Innovation Accelerator, the national Health IT Playbook, the ONC Patient Engagement Playbook for Providers, the SMART App Gallery, the FHIR at Scale Taskforce (FAST) Initiative, and is a founding Co-Chair of the Together.Health Collaborative.


EDMONDO ROBINSON
Chief Digital Officer
Moffitt Cancer Center

Dr. Robinson leads Moffitt’s Center for Digital Health which leverages the tools of IT, Health Data Services, Clinical Informatics and Digital Innovation to expand Moffitt’s ecosystem to deliver on consumer-oriented, real-world solutions for clinical practice, research, education, and administrative processes. In addition, he cares for Moffitt patients as part of the Internal and Hospital Medicine Program which includes teaching students and trainees. Previously, Dr. Robinson was the Chief Transformation Officer and Senior Vice President of Consumerism at ChristianaCare, one of the largest health systems in the mid-Atlantic.

Dr. Robinson is an associate professor at the University of South Florida’s Morsani College of Medicine. He serves as Chair of the National Advisory Council for the Agency for Healthcare Research and Quality and on the Board of Ardent Health. He is also a fellow of the American College of Physicians, a senior fellow of the Society of Hospital Medicine, and an Aspen Institute Health Innovators Fellow. He holds a medical degree from the David Geffen School of Medicine at the University of California, Los Angeles; an MBA with an emphasis in health care management from the Wharton School at the University of Pennsylvania; and a master’s degree in health policy research also from the University of Pennsylvania.



SHRUTI IYER
Principal Innovation Architect
Oracle

Shruti Iyer is a Principal Innovation Architect supporting Clinical Innovation in the Health Sciences Global Business Unit at Oracle. Shruti has had over seven years of experience at Medtronic as a subject matter expert in end-to-end medical device product development focusing on remote monitoring solutions for late-stage heart failure patients. Shruti has an M.S. in Medical Device Innovation from the University of Minnesota-Twin Cities where she was a Technological Leadership Institute Fellow. She is energized about driving complex and critical decisions in a highly regulated environment and is a thought leader with passion to empower patients to be in control of their health.